Efficacy and safety of capecitabine-temozolomide (CAPTEM) regimen in patients with neuroendocrine neoplasms - experience from NETwerk, a Belgian ENETS Center of Excellence

Bron
Acta gastro-enterologica belgica - ISSN 1784-3227-88:2 (2025) p. 119-127
Auteur(s)

Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients.

Bron
Scientific reports - ISSN 2045-2322-15:1 (2025) p. 1-15
Auteur(s)

Management of high-grade neuroendocrine neoplasms : impact of functional imaging.

Bron
Endocrine-related cancer - ISSN 1479-6821-32:4 (2025) p. 1-11
Auteur(s)
    Odeta Islam, K. Sarti, Lise Verbruggen, V. Vandersmissen, K. Vanden Bulcke, L. Annys, C. Verslype, J.L. Van Laethem, H. Rezaei Kalantari, J. Janssens, A. Hendlisz, P.J. Cuyle, G. Demolin, J. Decaestecker, K. Geboes, J.C. Coche, J. Van Ongeval, W. Lybaert, M. Peeters, I. Borbath, Timon Vandamme